Physician profile
Ryan C Corte
NPI 1336402445
$569,162.13
in general payments reported to CMS, 2019-2025
12 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $42K · 2021: $33K · 2022: $80K · 2023: $130K · 2024: $165K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $228K · Travel and Lodging: $75K · Consulting Fee: $46K · Food and Beverage: $13K · Entertainment: $390 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $227,821.38 |
| Travel and Lodging | $75,356.29 |
| Consulting Fee | $46,053.00 |
| Food and Beverage | $13,431.45 |
| Entertainment | $389.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $440,140.64 | 2022-2025 | Infuse, Infuse Multifocal, Multi-Focal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102,549.39 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $20,534.35 | 2019-2023 | Acuvue |
| Allergan, INC. | $2,329.98 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $1,047.50 | 2024 | |
| Apellis Pharmaceuticals, INC. | $933.00 | 2023 | |
| Optos, INC. | $646.84 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $596.74 | 2021-2025 | Precision7, Total30, Precision 1 |
| Coopervision INC. | $202.34 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $86.35 | 2024 | |
| Sun Pharmaceutical Industries INC. | $76.40 | 2025 | |
| Lkc Technologies, INC. | $18.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Corte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.